| Bioactivity | Deulorlatinib (compound A), a deuterated derivative of Lorlatinib (HY-12215), is a potent inhibitor of tyrosine kinase demonstrating desirable safety and durable activity in ALK-positive advanced NSCLC[1][2]. |
| CAS | 2131126-33-3 |
| Formula | C21H16D3FN6O2 |
| Molar Mass | 409.43 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Shenzhen TargetRx, Inc. Process for preparation of macrocycle. World Intellectual Property Organization, WO2017148325 A1 2017-09-08 |
Deulorlatinib
CAS: 2131126-33-3 F: C21H16D3FN6O2 W: 409.43
Deulorlatinib (compound A), a deuterated derivative of Lorlatinib (HY-12215), is a potent inhibitor of tyrosine kinase d
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.